SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-172476
Filing Date
2022-06-13
Accepted
2022-06-13 08:05:33
Documents
14
Period of Report
2022-06-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d324283d8k.htm   iXBRL 8-K 27455
2 EX-99.1 d324283dex991.htm EX-99.1 9339
6 GRAPHIC g324283dsp02.jpg GRAPHIC 8269
  Complete submission text file 0001193125-22-172476.txt   170614

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20220610.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20220610_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20220610_pre.xml EX-101.PRE 10817
8 EXTRACTED XBRL INSTANCE DOCUMENT d324283d8k_htm.xml XML 3213
Mailing Address 3000 HANOVER STREET PALO ALTO CA 94304
Business Address 3000 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 221010732
SIC: 8071 Services-Medical Laboratories